Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques
Cell · 2024-12 · 187 (25) · 7214-7231.e23
DOI: 10.1016/j.cell.2024.10.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024-12. Verfasst von Hua Wang und 59 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: HIV-1, Simian Immunodeficiency Virus, Simian Acquired Immunodeficiency Syndrome, Antibodies, Neutralizing. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Intramural NIH HHS, CCR NIH HHS.
Abstract (Originalsprache)
An antibody-based HIV-1 vaccine will require the induction of potent cross-reactive HIV-1-neutralizing responses. To demonstrate feasibility toward this goal, we combined vaccination targeting the fusion-peptide site of vulnerability with infection by simian-human immunodeficiency virus (SHIV). In four macaques with vaccine-induced neutralizing responses, SHIV infection boosted plasma neutralization to 45%-77% breadth (geometric mean 50% inhibitory dilution [ID50] ∼100) on a 208-strain panel. Molecular dissection of these responses by antibody isolation and cryo-electron microscopy (cryo-EM) structure determination revealed 15 of 16 antibody lineages with cross-clade neutralization to be directed toward the fusion-peptide site of vulnerability. In each macaque, isolated antibodies from memory B cells recapitulated the plasma-neutralizing response, with fusion-peptide-binding antibodies reaching breadths of 40%-60% (50% inhibitory concentration [IC50] < 50 μg/mL) and total lineage-concentrations estimates of 50-200 μg/mL. Longitudinal mapping indicated that these responses arose prior to SHIV infection. Collectively, these results provide in vivo molecular examples for one to a few B cell lineages affording potent, broadly neutralizing plasma responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Biochemistry and Molecular Biophysics and Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of P…
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Microscopy Unit, Research Technologies Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
- Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Förderung
- NIAID NIH HHS
- Intramural NIH HHS
- CCR NIH HHS
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases Vaccine Research Center
- Office of Science
- Frederick National Laboratory for Cancer Research
- National Institutes of Health
Zitieren
APA
Wang, H., Cheng, C., Dal Santo, J. L., Shen, C. H., Bylund, T., Henry, A. R., Howe, C. A., Hwang, J., Morano, N. C., Morris, D. J., Pletnev, S., Roark, R. S., Zhou, T., Hansen, B. T., Hoyt, F. H., Johnston, T. S., Wang, S., Zhang, B., Ambrozak, D. R., …, & Georgiev, I. S. (2024). Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques. Cell, 187(25), 7214-7231.e23. https://doi.org/10.1016/j.cell.2024.10.003
Vancouver
Wang H, Cheng C, Dal Santo JL, Shen CH, Bylund T, Henry AR, et al. Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques. Cell. 2024;187(25):7214-7231.e23. doi:10.1016/j.cell.2024.10.003
BibTeX
@article{Wang2024,
author = {Wang, Hua and Cheng, Cheng and Dal Santo, James L and Shen, Chen-Hsiang and Bylund, Tatsiana and Henry, Amy R and Howe, Colin A and Hwang, Juyun and Morano, Nicholas C and Morris, Daniel J and Pletnev, Sergei and Roark, Ryan S and Zhou, Tongqing and Hansen, Bryan T and Hoyt, Forrest H and Johnston, Timothy S and Wang, Shuyi and Zhang, Baoshan and Ambrozak, David R and Becker, Jordan E and Bender, Michael F and Changela, Anita and Chaudhary, Ridhi and Corcoran, Martin and Corrigan, Angela R and Foulds, Kathryn E and Guo, Yicheng and Lee, Myungjin and Li, Yingying and Lin, Bob C and Liu, Tracy and Louder, Mark K and Mandolesi, Marco and Mason, Rosemarie D and McKee, Krisha and Nair, Vinod and O'Dell, Sijy and Olia, Adam S and Ou, Li and Pegu, Amarendra and Raju, Nagarajan and Rawi, Reda and Roberts-Torres, Jesmine and Sarfo, Edward K and Sastry, Mallika and Schaub, Andrew J and Schmidt, Stephen D and Schramm, Chaim A and Schwartz, Cindi L and Smith, Sarah C and Stephens, Tyler and Stuckey, Jonathan and Teng, I-Ting and Todd, John-Paul and Tsybovsky, Yaroslav and Van Wazer, David J and Wang, Shuishu and Doria-Rose, Nicole A and Fischer, Elizabeth R and Georgiev, Ivelin S},
title = {Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques},
journal = {Cell},
year = {2024},
volume = {187},
number = {25},
pages = {7214--7231.e23},
doi = {10.1016/j.cell.2024.10.003}
}
EUVIMED